Data show cardiometabolic benefits of Type 2 diabetes treatment
Orphan Drug Designation for potential best-in-class ADC for sarcoma
FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment
Servier acquiring Edgewise Therapeutics’ muscular dystrophy business